Search results
Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.
- Disclaimer
Disclaimer - BiliTool - Newborn values:
- BiliTool EMR
Five (5) are required (ageHours, totalBilirubin,...
- FAQ
Can I use BiliTool with transcutaneous bilirubin? TcB...
- Subscribe
Subscribe - BiliTool - Newborn values:
- About
About - BiliTool - Newborn values:
- Latest Features
October-November 2022 Updates. We are pleased to announce...
- Neurotoxicity Risk Factors
Neurotoxicity Risk Factors - BiliTool - Newborn values:
- BiliTool
The 2022 AAP Guideline (see KAS 7) has established a rapid...
- Disclaimer
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
19 maj 2010 · This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.
5 sie 2022 · The 2004 guideline made recommendations for primary prevention (eg, maternal Rh typing and treatment) and secondary prevention (eg, risk- factor assessment and close monitoring for the development of hyperbilirubinemia, and, when necessary, treatment).
1 cze 2007 · Hyperbilirubinemia is very common and usually benign in the term newborn infant and the late preterm infant at 35 to 36 completed weeks’ gestation. Critical hyperbilirubinemia is uncommon but has the potential for causing long-term neurological impairment.
These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool. (Both are available online at www.nice.org.uk/guidance/CG98) Issue date: May 2010
• Bhutani curve (below) is the accepted nomogram for assessing hyperbilirubinemia risk for infants ≥ 35 weeks gestation, based on bilirubin level and postnatal age © Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital